Insider Transactions in Q4 2025 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
4,084
-14.01%
|
$93,932
$23.69 P/Share
|
|
Nov 18
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,262
-16.14%
|
$236,026
$23.69 P/Share
|
|
Nov 17
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,932
+12.79%
|
-
|
|
Nov 17
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
19,826
+14.54%
|
-
|
|
Nov 10
2025
|
James M Daly |
SELL
Open market or private sale
|
Direct |
30,000
-88.13%
|
$660,000
$22.37 P/Share
|